We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical cosmetic ingredient — not a dietary supplement
Niacinamide is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Niacinamide studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 1995–2022 with a typical study size of 50 participants.
Based on 7 studies · 5 RCTs · 301 total participants
Confidence
ModerateBy outcome
Niacinamide has an evidence score of 6/10 — moderate evidence based on 7 indexed studies. A topical cosmetic form of vitamin B3 — a leave-on skincare active applied to the skin, NOT (in this context) an ingested supplement. Niacinamide (nicotinamide) is one of the better-evidenced cosmetic actives: short, double-blind, split-face trials — many run or funded by Procter & Gamble — show real but modest improvements in hyperpigmentation, fine lines, sallowness, sebum, and the skin barrier at roughly 2-5%. It is mechanistically plausible (it boosts ceramide/barrier-lipid synthesis and reduces transfer of pigment to skin cells) and consistently well tolerated. The honest framing: it is generally an ADJUVANT rather than a first-line active — in head-to-head pigmentation trials hydroquinone still edges it out — and most trials are small and industry-linked. These are cosmetic appearance outcomes, not health outcomes. (Separately, ORAL nicotinamide has its own, unrelated evidence for reducing non-melanoma skin cancers — that is a different, ingested use and not what this topical entry covers.) Representative study: PMID 35642229.
Vitamin C (topical)
Mostly mechanism / observationalTopical vitamin C — a leave-on antioxidant skincare active applied to the skin, NOT (in this context) an oral vitamin C supplement. As L-ascorbic acid or a stabilized derivative, it has a strong rationale: vitamin C is an essential cofactor for collagen synthesis and a free-radical scavenger that supports photoprotection. Small, vehicle-controlled split-face trials show genuine but modest improvements in wrinkles, skin texture, and pigmentation, and it has a consistent brightening/depigmenting signal. The honest framing: the whole topical-vitamin-C trial base is tiny (a systematic review pooled ~7 studies and ~139 people), formulations are notoriously unstable (they oxidise and lose potency), and most positive trials combine vitamin C with vitamin E, ferulic acid, or other actives — so vitamin-C-alone efficacy is hard to isolate. These are cosmetic appearance outcomes, not health outcomes, and it is not a sunscreen substitute.
Practical, evidence-based guides that cover Niacinamide.
Explore: Best supplements for Skin, Hair & Beauty
Last reviewed June 2026 · evidence from 7 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Niacinamide (topical nicotinamide, vitamin B3)
A topical cosmetic form of vitamin B3 — a leave-on skincare active applied to the skin, NOT (in this context) an ingested supplement. Niacinamide (nicotinamide) is one of the better-evidenced cosmetic actives: short, double-blind, split-face trials — many run or funded by Procter & Gamble — show real but modest improvements in hyperpigmentation, fine lines, sallowness, sebum, and the skin barrier at roughly 2-5%. It is mechanistically plausible (it boosts ceramide/barrier-lipid synthesis and reduces transfer of pigment to skin cells) and consistently well tolerated. The honest framing: it is generally an ADJUVANT rather than a first-line active — in head-to-head pigmentation trials hydroquinone still edges it out — and most trials are small and industry-linked. These are cosmetic appearance outcomes, not health outcomes. (Separately, ORAL nicotinamide has its own, unrelated evidence for reducing non-melanoma skin cancers — that is a different, ingested use and not what this topical entry covers.)
Multiple double-blind, vehicle- or comparator-controlled trials show real but modest cosmetic-appearance benefits across several outcomes (pigmentation, fine lines, sebum, acne, barrier), with plausible mechanisms and excellent tolerability — but trials are small, short, often industry-linked, and niacinamide trails first-line actives head-to-head.
Niacinamide, also called nicotinamide, is the amide form of vitamin B3 used as a water-soluble leave-on active in cosmetics, typically at 2-5%. This entry covers its TOPICAL cosmetic use on the skin — it is not about swallowing a B3 supplement.
As a precursor of the cofactors NAD+/NADP+, niacinamide supports keratinocyte energy metabolism, and topically it has several documented actions: it increases the biosynthesis of ceramides and other stratum-corneum barrier lipids (via upregulation of serine palmitoyltransferase), which lowers transepidermal water loss; it inhibits the transfer of pigment-laden melanosomes from melanocytes to keratinocytes (35-68% inhibition in coculture) without affecting tyrosinase, which is how it lightens hyperpigmentation; and it has anti-inflammatory and sebum-modulating effects.
The clinical evidence is moderate and unusually broad for a cosmetic active, but leans heavily on short, often industry-linked trials.
The foundational facial-aging study (Bissett et al., Dermatol Surg 2005) was a 12-week double-blind split-face RCT of 5% niacinamide that found significant reductions versus vehicle in fine lines/wrinkles, hyperpigmented spots, red blotchiness, and sallowness, with improved elasticity by cutometry.
For pigment specifically, Hakozaki et al. (2002) tied the melanosome-transfer mechanism to a clinical reduction in hyperpigmentation and increased skin lightness by four weeks.
An independent (non-industry) split-face RCT in melasma (Navarrete-Solís et al., 2011) is the key counterweight: both 4% niacinamide and 4% hydroquinone improved pigment with no significant colorimetric difference, but good-to-excellent response was lower with niacinamide (44%) than hydroquinone (55%) — niacinamide was better tolerated but slightly less effective, which is why reviews position it as an adjuvant rather than a first-line lightener.
Niacinamide also has antibiotic-free acne data (4% nicotinamide gel performed comparably to 1% clindamycin gel over 8 weeks), a modest, population-dependent sebum-lowering effect, and a barrier benefit that rests mainly on in-vitro plus a small in-vivo component.
The honest caveats: trials are small (often n=18-50), short (4-12 weeks), and frequently linked to ingredient or product manufacturers; the anti-wrinkle/elasticity and sebum effects are the thinnest parts of the evidence, while pigmentation and acne are the most robust.
None of this is a health claim about the cream: niacinamide is a lawful, well-tolerated cosmetic whose documented topical benefit is a modest improvement in skin tone, texture, barrier, and clarity.
(To avoid conflation: ORAL nicotinamide 500 mg twice daily has separately been shown in a phase-3 RCT to reduce new non-melanoma skin cancers — a systemic, ingested use that is unrelated to topical cosmetic application and is not represented in this entry's curated studies.) It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
Niacinamide upregulates serine palmitoyltransferase and increases the biosynthesis of ceramides, free fatty acids, and cholesterol in the stratum corneum. The result is a stronger epidermal permeability barrier and reduced transepidermal water loss (TEWL), which underlies its hydration and anti-sallowness benefits.
Niacinamide reduces the transfer of pigment-laden melanosomes from melanocytes to surrounding keratinocytes (35-68% inhibition in coculture) without affecting tyrosinase or melanin synthesis itself. This is the route by which it lightens existing hyperpigmentation and evens skin tone.
As a precursor of NAD+/NADP+, niacinamide supports keratinocyte energy metabolism and has anti-inflammatory activity, which contributes to reduced redness and its antibiotic-free benefit in inflammatory acne, plus a modest, population-dependent reduction in sebum.
Topical cosmetic only. Niacinamide is typically formulated at 2-5% in leave-on serums, creams, or gels and applied to clean skin once or twice daily (AM and/or PM). It layers well under sunscreen and with most other actives. There is no oral, injectable, or systemic dose in this cosmetic context — it is not ingested here. This library does not provide an ingestion protocol.
| Form | Type |
|---|---|
| 🧴Leave-on topical serum or cream (2-5% niacinamide) | Recommended |
| 💊Combination brightening or barrier formulas containing niacinamide | Alternative |
There is no oral or injectable form in this cosmetic context. Niacinamide is a skincare active applied to the skin surface; oral vitamin B3 is a separate, ingested use.
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Applied topically to clean skin, commonly AM and/or PM. As a well-tolerated leave-on cosmetic there is no ingestion or meal-timing consideration; it layers easily with most other skincare actives.
Every documented benefit here is a modest improvement in the APPEARANCE of skin (tone, texture, clarity, barrier). Topical niacinamide is a cosmetic ingredient, not an ingested supplement in this context; it does not treat any disease. (Oral nicotinamide's skin-cancer-prevention evidence is a separate, unrelated use.)
Controlled trials show significant reduction in hyperpigmented spots and increased skin lightness by around 4 weeks. This is the most robust topical benefit, though it is an adjuvant — hydroquinone is modestly more effective head-to-head.
By boosting ceramide and barrier-lipid synthesis, niacinamide lowers transepidermal water loss and improves the look of dull, sallow, or blotchy skin.
4% nicotinamide gel performed comparably to 1% clindamycin gel for inflammatory acne over 8 weeks, and 2% niacinamide reduced sebum on some measures/populations — a modest, context-dependent effect.
Reviews position niacinamide as an effective, well-tolerated adjuvant rather than a gold-standard treatment. For pigmentation specifically, hydroquinone and triple-combination therapy have stronger evidence.
Across trials niacinamide is associated with low irritation — fewer side effects than hydroquinone in head-to-head melasma data. Occasional mild irritation or transient flushing is possible.
Topical niacinamide is generally considered low-concern and is often suggested as a gentle alternative to retinoids, but it has not been formally studied in pregnancy or lactation; discuss any skincare active with a clinician.
Usually well tolerated and often soothing; still patch-test and introduce alongside, not on top of, other strong actives.
Manage expectations — niacinamide is an adjuvant; hydroquinone or triple-combination therapy under a clinician has stronger pigment evidence, and daily sunscreen is essential.
An old concern that mixing niacinamide with pure low-pH ascorbic acid forms niacin and causes transient flushing; in modern formulations this is largely a non-issue, and the two are commonly layered. This is a tolerability/formulation note, not a systemic drug interaction — niacinamide is not ingested here.
Niacinamide is usually soothing and layers well, but combining many strong actives at once can still irritate sensitive skin. Introduce one new active at a time. Not a systemic interaction.
Tip: Patch-test before facial use; reduce frequency or concentration if irritation occurs.
Tip: Usually settles quickly; choose a lower concentration or a different formulation if bothersome.
The commonly studied dose of Niacinamide is Topical cosmetic only. Niacinamide is typically formulated at 2-5% in leave-on serums, creams, or gels and applied to clean skin once or twice daily (AM and/or PM). It layers well under sunscreen and with most other actives. There is no oral, injectable, or systemic dose in this cosmetic context — it is not ingested here. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Niacinamide — consistent daily use matters more than the time of day. Niacinamide is a water-soluble leave-on topical with no meal-timing relationship; it is well tolerated and stable enough for AM and/or PM use and layers easily under sunscreen and over other actives.
Niacinamide is generally well-tolerated and considered safe for most healthy adults at recommended doses. The most commonly reported side effects are mild local irritation or redness, transient flushing or tingling. Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection (in this cosmetic context); Known allergy or sensitivity to niacinamide or formulation excipients; Application to broken, irritated, or compromised skin until healed.
Tretinoin (Retin-A)
Mostly mechanism / observationalA prescription TOPICAL retinoid (Retin-A, Renova) — the acid form of vitamin A and the gold-standard, best-evidenced topical treatment for photoaging and acne. Multiple double-blind RCTs show it reduces fine wrinkles, mottled hyperpigmentation, and roughness over months, with histologic increases in dermal collagen. Caveats: retinoid dermatitis (irritation, peeling, dryness), photosensitivity, and it is CONTRAINDICATED IN PREGNANCY. Prescription drug, not a supplement; distinct from weaker OTC 'retinol' cosmetics.
The depigmenter playbook (hydroquinone, azelaic, tranexamic, vitamin C) with sunscreen as the spine.